Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
10.50
-0.60 (-5.41%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $387.59 million as of April 25, 2025.
Market Cap
387.59M
Enterprise Value
83.79M
1-Year Change
n/a
Ranking
Category
Stock Price
10.50
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $387.59M, a decrease of -35.55%. That is a compound annual growth rate of -39.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 387.59M | -40.27% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |